2 unchanged sentences
Incorporated by Reference
+Added: Agreement and Plan of Merger, dated as of May 23, 2022, by and among Innoviva, Inc., Innoviva Merger Sub, Inc.
+Added: and Entasis Therapeutics Holdings Inc.
+Added: Agreement and Plan of Merger, dated as of July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc.
+Added: and La Jolla Pharmaceutical Company
Amended and Restated Certificate of Incorporation
10 unchanged sentences
Indenture (including form of Note) with respect to Innoviva’s 2.125% Convertible Senior Notes due 2028, dated as of March 7, 2022, between Innoviva and The Bank of New York Mellon Trust Company, N.A., as trustee
−Removed: Form of Capped Call Confirmation
+Added: Offer Letter between Innoviva, Inc.
+Added: and Pavel Raifeld, dated April 29, 2022
+Added: Amendment No.
+Added: 1 to the Investor Rights Agreement, dated May 23, 2022, by and among Innoviva, Inc.
+Added: and Entasas Therapeutics Holdings Inc
+Added: Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and Kevin C.
+Added: Tang Foundation
+Added: Equity Purchase Agreement, dated July 13, 2022, by and among Innoviva, Inc., Innoviva TRC Holdings LLC and Royalty Pharma Investments 2019 ICAV.
+Added: Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC.
Certification of Principal Executive Officer pursuant to Rules 13a‑14 pursuant to the Securities Exchange Act of 1934
11 unchanged sentences
Innoviva, Inc.
+Added: July 27, 2022
/s/ Pavel Raifeld
2 unchanged sentences
(Principal Executive Officer)
+Added: July 27, 2022
/s/ Marianne Zhen
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.